Smith+Nephew quarterly revenue gets boost as elective surgeries recover

Oct 29 (Reuters) - Smith+Nephew said on Thursday revenue recovered strongly in the third quarter from the second, as hospitals managed to carry out more elective surgeries after the initial wave of coronavirus infections.

The company, which makes orthopaedic implants and prosthetics, said sales fell nearly 4% to $1.2 billion in the three months ended Sept. 26, recovering from a near 30% slump in the second quarter.


Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.

Sign up for a free trial of our full service at and follow us on Twitter @Breakingviews and at All opinions expressed are those of the authors.